Prediction of intratumoral TIGIT receptor occupancy after the treatment with anti-TIGIT antibodie

被引:0
|
作者
Shchelokov, Dmitry [1 ]
Demin, Oleg, Jr. [1 ]
Demin, Oleg [1 ]
Rizwan, Ahsan [2 ]
Zhang, Yun [3 ]
Tan, Wei [4 ]
Sahasranaman, Srikumar [2 ]
Budha, Nageshwar [2 ]
机构
[1] InSysBio, Moscow, Russia
[2] BeiGene USA Inc, San Mateo, CA USA
[3] BeiGene Beijing Co Ltd, Beijing, Peoples R China
[4] BeiGene Shanghai Co Ltd, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5421
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Anti-TIGIT in the liver
    Landman, Allison
    [J]. LANCET ONCOLOGY, 2023, 24 (07): : 724 - 724
  • [2] Pharmacodynamic biomarkers for anti-TIGIT treatment and prevalence of TIGIT expression in multiple solid tumor types
    Cattaruzza, Fiore
    Yeung, Pete
    Wang, Min
    Brunner, Alayne
    Le Scolan, Erwan
    Cain, Jennifer
    Argast, Gretechen
    O'Young, Gilbert
    Liu, YuWang
    Cancilla, Belinda
    Gurney, Austin
    Hoey, Tim
    Lewicki, John
    Kapoun, Ann
    [J]. CANCER RESEARCH, 2017, 77
  • [3] Anti-TIGIT therapies for solid tumors: a systematic review
    Rousseau, A.
    Parisi, C.
    Barlesi, F.
    [J]. ESMO OPEN, 2023, 8 (02)
  • [4] Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer
    Vaia Florou
    Ignacio Garrido-Laguna
    [J]. Current Oncology Reports, 2022, 24 : 1107 - 1112
  • [5] GSK to buy iTeos's anti-TIGIT antibody
    Satyanarayana, Megha
    [J]. CHEMICAL & ENGINEERING NEWS, 2021, 99 (23) : 11 - 11
  • [6] EVALUATION OF THE TIGIT+ IMMUNE SUBSET DEPLETION EFFECT OF THE ANTI-TIGIT ANTIBODY M6223
    Xu, Chunxiao
    Yalavarthi, Sireesha
    Bourin, Clotilde
    Moisan, Jacques
    Blaukat, Andree
    Helming, Laura
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A518 - A518
  • [7] Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer
    Florou, Vaia
    Garrido-Laguna, Ignacio
    [J]. CURRENT ONCOLOGY REPORTS, 2022, 24 (09) : 1107 - 1112
  • [8] Functional anti-TIGIT antibodies modulate T cell responses in vivo
    Dixon, K.
    Schorer, M.
    Nevin, J.
    Etminan, Y.
    Amoozgar, Z.
    Kondo, T.
    Kurtulus, S.
    Kassam, N.
    Sobel, R.
    Fukumura, D.
    Jain, R.
    Anderson, A.
    Kuchroo, V
    Joller, N.
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 4S - 4S
  • [9] RAPIDLY PROGRESSIVE EOSINOPHILIC PNEUMONIA SECONDARY TO PEMBROLIZUMAB AND ANTI-TIGIT THERAPY
    Mohammed, Asna
    Tang, Bo
    Barmaimon, Guido
    Sadikot, Sean
    [J]. CHEST, 2023, 164 (04) : 6223A - 6224A
  • [10] Unlocking the Potential of Anti-TIGIT Therapy-Between Promise and Challenges
    Hajjar, Joud
    Derbala, Mohamed H.
    Naing, Aung
    [J]. JAMA ONCOLOGY, 2023, 9 (11) : 1503 - 1504